NTRA · Insider Trading

Natera, Inc. Common Stock

Full NTRA quote
Iron condor setupsExpected moveIV rank historyFibonacci levelsInsider trading

Every open-market purchase and sale reported by NTRA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
45
code S
Reporting Insiders
16
current holders
NTRA — Recent Form 4 Transactions (latest 2026-10-09)
FiledInsiderRole TypeSharesValue
2026-10-09 Matthew Rabinowitz EXECUTIVE CHAIRMAN G −6,000 —
2026-10-02 Steven Leonard Chapman CEO AND PRESIDENT Sell −1,273 −$526.14K
2026-10-02 Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS Sell −3,000 −$1.24M
2026-09-25 Jonathan Sheena Director Sell −18,064 −$7.01M
2026-09-18 Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS G −945 —
2026-09-17 Jonathan Sheena Director Sell −9,150 −$3.22M
2026-09-16 Matthew Rabinowitz EXECUTIVE CHAIRMAN Sell −102,000 −$34.80M
2026-09-11 Matthew Rabinowitz EXECUTIVE CHAIRMAN Sell −50,000 −$16.40M
2026-09-03 Steven Leonard Chapman CEO AND PRESIDENT Sell −1,698 −$545.04K
2026-09-03 Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS Sell −18,160 −$5.92M
2026-08-28 John Fesko PRESIDENT, CHIEF BUS. OFFICER MIXED +13,483 −$2.10M
2026-08-14 Jonathan Sheena Director Sell −6,000 −$1.95M
2026-08-07 Jonathan Sheena Director Sell −9,150 −$2.89M
2026-08-07 Matthew Rabinowitz EXECUTIVE CHAIRMAN Sell −2,000 −$641.80K
2026-08-07 Matthew Rabinowitz EXECUTIVE CHAIRMAN Sell −2,000 −$641.80K
2026-08-07 Jonathan Sheena Director Sell −9,150 −$2.89M
2026-08-05 John Fesko PRESIDENT, CHIEF BUS. OFFICER Sell −295 −$79.06K
2026-08-05 Michael Burkes Brophy CHIEF FINANCIAL OFFICER Sell −795 −$216.03K
2026-08-05 Steven Leonard Chapman CEO AND PRESIDENT Sell −3,076 −$819.43K
2026-08-05 Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS Sell −3,410 −$905.63K
2026-08-05 Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER Sell −334 −$89.51K
2026-08-05 Matthew Rabinowitz EXECUTIVE CHAIRMAN Sell −731 −$195.90K
2026-08-05 Jonathan Sheena Director Sell −109 −$29.21K
2026-07-29 Steven Leonard Chapman CEO AND PRESIDENT Sell −5,770 −$1.48M
2026-07-29 Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER Sell −1,887 −$485.11K
2026-07-29 Michael Burkes Brophy CHIEF FINANCIAL OFFICER Sell −5,064 −$1.28M
2026-07-29 Matthew Rabinowitz EXECUTIVE CHAIRMAN Sell −1,718 −$447.52K
2026-07-29 Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS Sell −2,214 −$569.00K
2026-07-29 John Fesko PRESIDENT, CHIEF BUS. OFFICER Sell −1,713 −$440.24K
2026-07-29 Jonathan Sheena Director Sell −479 −$123.55K
2026-07-17 Rowan E Chapman Director Sell −135 −$37.10K
2026-07-17 Jonathan Sheena Director Sell −1,500 −$410.83K
2026-07-15 Jonathan Sheena Director Sell −3,150 −$836.90K
2026-07-08 Matthew Rabinowitz EXECUTIVE CHAIRMAN Sell −1,000 −$280.00K
2026-07-06 Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS Sell −3,000 −$818.71K
2026-07-06 Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER Sell −16,800 −$4.57M
2026-06-26 Herm Rosenman Director Sell −16,530 −$4.13M
2026-06-26 Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER Sell −33,600 −$8.46M
2026-06-22 Jonathan Sheena Director Sell −1,500 −$329.81K
2026-06-17 Rowan E Chapman Director Sell −2,964 −$642.54K
2026-06-17 Jonathan Sheena Director Sell −3,150 −$665.09K
2026-06-16 Matthew Rabinowitz EXECUTIVE CHAIRMAN Sell −100,000 −$21.45M
2026-06-09 Gail Boxer Marcus Director MIXED — −$2.14M
2026-06-05 Steven Leonard Chapman CEO AND PRESIDENT Sell −41,124 −$9.09M
2026-06-03 Roelof Botha Director Sell −78,000 −$17.18M
2026-06-03 Eric H Rubin Director A +2,124 —
2026-06-03 Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS Sell −3,000 −$655.29K
2026-05-28 John Fesko PRESIDENT, CHIEF BUS. OFFICER Sell −1,438 −$291.68K
2026-05-28 Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS Sell −1,652 −$335.09K
2026-05-15 Jonathan Sheena Director Sell −4,650 −$959.45K
NTRA — Current Insider Holders
InsiderRole Shares HeldValue
Matthew Rabinowitz EXECUTIVE CHAIRMAN 2,119,394 $833.85M
James Healy Director 1,596,540 $628.14M
Roelof Botha Director 1,079,092 $424.56M
Jonathan Sheena Director 238,956 $94.01M
John Fesko PRESIDENT, CHIEF BUS. OFFICER 197,257 $77.61M
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER 170,073 $66.91M
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS 106,914 $42.06M
Steven Leonard Chapman CEO AND PRESIDENT 96,926 $38.13M
Michael Burkes Brophy CHIEF FINANCIAL OFFICER 51,637 $20.32M
Roy D. Baynes Director 18,512 $7.28M
Gail Boxer Marcus Director 6,183 $2.43M
Brinkley Ruth Williams Director 5,475 $2.15M
Monica Bertagnolli Director 5,374 $2.11M
Rowan E Chapman Director 4,663 $1.83M
Herm Rosenman Director 4,250 $1.67M
Eric H Rubin Director 2,129 $837.63K
NTRA Insider Trading FAQ
Who are the insiders at NTRA?
16 officers, directors and 10%+ beneficial owners currently report holdings in NTRA via SEC Form 4.
Are NTRA insiders buying or selling?
Across the 50 most recent Form 4 filings for NTRA, 0 were open-market purchases (code P) and 45 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is NTRA insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent NTRA filing is dated 2026-10-09.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the NTRA quote page; the site-wide leaderboard is on the insider transactions hub.

More on NTRA
NTRA full quote Insider Transactions Hub (all symbols) NTRA iron condor setups NTRA expected move NTRA IV rank history NTRA Fibonacci levels

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.